Atlas Trials

Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma

Clinical trial NCT01334112 · COMPLETED

Trial details

NCT number
NCT01334112
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2011-01-01
Primary completion
2018-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.